Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Assessing Your Oral Vaccine Candidate COVID-19 Tablet
Vaxart announces the publication of a peer-reviewed newspaper article showing the potential clinical and economic value of a norovirus vaccine